PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23268412-6	2012	Rosiglitazone treatments significantly lowered the contents of total cholesterol and free cholesterol (P<0.05), decreased the expression of ACAT-1 (P<0.05), and increased SR-BI expression (P<0.05) in the foam cells in a dose-dependent manner.	Rosiglitazone	0-13	scavenger receptor class B, member 1	Mus musculus	177-182	
23268412-7	2012	CONCLUSION: Rosiglitazone can decrease the contents of total and free cholesterol, down-regulate ACAT-1 expression and up-regulate SR-BI expression in the foam cells produce the anti-atherosclerotic effect.	Rosiglitazone	12-25	scavenger receptor class B, member 1	Mus musculus	131-136	
22240665-9	2012	SR-BI protein was increased by rosiglitazone but LPS decreased the levels.	Rosiglitazone	31-44	scavenger receptor class B, member 1	Mus musculus	0-5